San Diego, CA, United States of America

Eve Merriman

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Atyr Pharma, Inc.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eve Merriman. Retrieved from https://idiyas.com/inventor/eve-merriman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eve Merriman - Innovator in Biochemical Research

Introduction

Eve Merriman is a notable inventor based in San Diego, CA (US). She has made significant contributions to the field of biochemical research, particularly in the area of tRNA synthetases. Her work has implications for various biological processes and potential therapeutic applications.

Latest Patents

Eve Merriman holds a patent for "Compositions and methods comprising aspartyl-tRNA synthetases having non-canonical biological activities." This patent includes isolated aspartyl-tRNA synthetase polypeptides and polynucleotides that exhibit non-canonical biological activities, along with related compositions and methods.

Career Highlights

Merriman is currently associated with Atyr Pharma, Inc., where she continues to advance her research in the field. Her innovative work has positioned her as a key figure in the development of new biochemical applications.

Collaborations

Eve has collaborated with notable colleagues, including Ryan Andrew Adams and Fei Hong, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Eve Merriman's contributions to biochemical research and her innovative patent highlight her role as a leading inventor in her field. Her work continues to inspire advancements in biotechnology and therapeutic development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…